Literature DB >> 18280803

Regulation of ribosomal protein S6 kinases by ubiquitination.

Mong-Lien Wang1, Ganna Panasyuk, Jodie Gwalter, Ivan Nemazanyy, Tim Fenton, Valeriy Filonenko, Ivan Gout.   

Abstract

Ribosomal protein S6 kinase (S6K) is a key player in the regulation of cell growth and energy metabolism via the mTOR and PI3K signalling pathways. The activity and subcellular localization of S6K are regulated by multiple S/T phosphorylations in response to diverse extracellular stimuli. Downregulation of S6K signalling occurs through the action of S/T phosphatases (PP2A and PP1) and tumor suppressors (TSC1/2 and PTEN). We report here that, in addition to phosphorylation, S6Ks are ubiquitinated in cells. The pattern of ubiquitination and the effect of proteasomal inhibitors on the steady-state level of transiently overexpressed and endogenous S6Ks point to proteasome-mediated degradation of ubiquitinated S6Ks. Furthermore, we found that the site(s) of ubiquitination are located in the kinase domain and that the N- and C-terminal regulatory regions modulate the efficiency of S6K ubiquitination. This study suggests that S6K signalling also could be regulated through the proteasome-mediated turnover of S6Ks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280803     DOI: 10.1016/j.bbrc.2008.02.032

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Deubiquitylating enzyme, USP9X, regulates proliferation of cells of head and neck cancer lines.

Authors:  D M Nanayakkara; M N Nguyen; S A Wood
Journal:  Cell Prolif       Date:  2016-07-04       Impact factor: 6.831

2.  Differential genomic responses in old vs. young humans despite similar levels of modest muscle damage after resistance loading.

Authors:  Anna E Thalacker-Mercer; Louis J Dell'Italia; Xiangqin Cui; James M Cross; Marcas M Bamman
Journal:  Physiol Genomics       Date:  2009-11-10       Impact factor: 3.107

3.  Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells.

Authors:  Neil E Kay; Traci Sassoon; Charla Secreto; Sutapa Sinha; Tait D Shanafelt; Asish K Ghosh; Jack L Arbiser
Journal:  Leuk Lymphoma       Date:  2016-05-17

4.  CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools.

Authors:  Pradeep Sathyanarayana; Estelle Houde; Deborah Marshall; Amy Volk; Dorie Makropoulos; Christine Emerson; Anamika Pradeep; Peter J Bugelski; Don M Wojchowski
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113

5.  Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 Activation.

Authors:  Jin Zhang; Zhanguo Gao; Jianping Ye
Journal:  Biochim Biophys Acta       Date:  2013-06-28

6.  Inactivation of NF-kappaB p50 leads to insulin sensitization in liver through post-translational inhibition of p70S6K.

Authors:  Zhanguo Gao; Jun Yin; Jin Zhang; Qing He; Owen P McGuinness; Jianping Ye
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

7.  Unrestrictive identification of non-phosphorylation PTMs in yeast kinases by MS and PTMap.

Authors:  Kai Zhang; Yue Chen; Zhihong Zhang; Shengce Tao; Heng Zhu; Yingming Zhao
Journal:  Proteomics       Date:  2010-03       Impact factor: 3.984

Review 8.  Beyond controlling cell size: functional analyses of S6K in tumorigenesis.

Authors:  Xueji Wu; Wei Xie; Wenxuan Xie; Wenyi Wei; Jianping Guo
Journal:  Cell Death Dis       Date:  2022-07-25       Impact factor: 9.685

9.  S6K2: The Neglected S6 Kinase Family Member.

Authors:  Olivier E Pardo; Michael J Seckl
Journal:  Front Oncol       Date:  2013-07-24       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.